A web-based DNA health analysis platform that turns raw genetic data into a structured, easy-to-read modular health workspace. Pharmacogenetics, polygenic risk scores, carrier screening, monogenic findings — each in its own card, each with confidence and coverage. Educational, never diagnostic.
Most consumer DNA-health tools collapse the entire output into a single anxiety-inducing risk score. Health Studio does the opposite. It gives you independent modular reports — one for pharmacogenetics, one for cardiometabolic PRS, one for traits, one for monogenic findings, one for carrier panels — each with its own confidence tier and coverage notes.
Under the hood, Health Studio runs a unified analysis engine across SNP databases (traits, PRS, monogenic, PGx, aging) plus optional ClinVar / GWAS-derived sources. Each report module is built independently and rendered with plain-language explanations, evidence citations, population context, and limitations.
It is positioned as educational, not diagnostic. Every card carries that framing explicitly. The point is informed, calibrated reading of your genome — not headlines.
Open only the surfaces that matter to you today. Each card is independent and self-contained.
Cardiometabolic, neuro (with APOE spotlight), lipid trends, vitamin trends. Each PRS shows population, year, N, evidence tier, and limitations.
Coverage notesPhenotype-oriented trait report — eye / hair / skin and related traits. Includes genes, key variants, and per-column help hints.
Phenotype-styleCurated essential pharmacogenetic markers — the ones a clinician would want to know first.
Curated panelFull PGx-actionable variant report from the unified database. Drug-gene relationships with strength of evidence.
ActionableSubset focused on safety and toxicity-related drug-gene findings. Surfaced separately for emphasis.
Safety subsetDrug-gene markers most relevant to therapeutic efficacy. Useful for medication-decision conversations.
Efficacy subsetMarkers relevant to drug metabolism rate and dosing — slow / normal / rapid metaboliser categories.
MetabolismCurated classic-screening panel — the kind of standard screening markers a clinical service would surface.
Classic panelMonogenic trait-focused subset; reportable variants align with ACMG-style framings where possible.
ACMG-alignedSpotlight on clinically annotated variants from the unified DB (ClinVar-derived signals included).
AnnotatedTargeted caffeine-metabolism panel with practical guidance on what the variants mean.
LifestyleVariant matching against an aging/longevity database — markers studied for longevity correlations.
Research-gradeSame upload as the rest of NexoGENO. Vendor formats auto-detected. VCF accepted for full coverage.
Per-marker coverage is checked. Missing SNPs are flagged as "not covered" — never silently filled.
PGx, PRS, traits, monogenic, carrier, aging — each module runs its own analysis with its own confidence model.
Every card explains what was tested, what was found, what's known, what's not, and what the appropriate caveat is.
Click a thumbnail to swap. Real screenshots from the shipping product.
Each report card is independent. Open the ones you need today, ignore the rest. No forced narrative.
Every PRS row carries population, year, N, and evidence tier. Weak-confidence findings get explicit warnings.
Each module surfaces its strongest signals first; in-report term filtering helps you drill in by topic.
No "you carry the gene for X" headlines. Every variant is explained with appropriate context and caveat.
Per-PRS coverage check. If your raw file doesn't include the relevant SNPs, the system says so explicitly.
HTML reports, image exports, JSON for downstream tooling. Your data leaves the platform with you.
Every output explicitly carries the educational framing. We are not your doctor; we surface the evidence so you can talk to one.
New PRS panels, new ClinVar releases, new PGx evidence — pulled in via the data update wizard, no re-buying.
Your raw genome is not sold or syndicated. Job results live on your account. Deletion is real.
Zoomed-in views of specific surfaces inside the platform. Pulled from the live product, not mocked up.
The dashboard is the orientation layer. Every independent module shows up as its own card with its own coverage, confidence, and entry point. Open one card or all of them — the platform doesn't force a narrative on you.
Population, year, N, evidence tier, limitations — surfaced inline, per row. Weak-confidence findings are flagged explicitly. The opposite of single-number risk-score consumer tests.
Eye / hair / skin and related traits, presented with genes and key variants visible. Per-column help hints, searchable, exportable. Consumer-test friendly framing for the lighter end of your genome.
Actionable PGx variants from the unified database, with drug-gene relationships and strength-of-evidence visible per row. Sliced four ways across the deck (Essential, Safety, Efficacy, Metabolism) for the specific question you're asking.
PGx isn't one thing — it's many. Health Studio splits it into four reports: Essential PGx (the curated must-knows), Actionable (the full evidence-supported set), Safety (toxicity-focused), Efficacy (treatment-response-focused), and Metabolism (dose-related).
Each subset is built from the same unified database but framed for the specific question you're asking — and each row carries strength-of-evidence so you know which findings to bring to a clinician.
Subscribe
Population baselines explained, evidence tier shown, weak findings flagged. The opposite of consumer-test melodrama.
The Pharmacogenetics + Clinical Variants modules give you something you can actually bring to a clinician without translation.
ClinVar, GWAS-derived PRS, PGx evidence — all kept current via the data update wizard. Your subscription buys living science.
/api/jobs/{id}/premium; HTML and image exports are produced for every module; per-card searchable tables let you copy out specific findings.Health-grade analysis with continuous data refreshes (ClinVar, GWAS, PGx evidence) costs us money to keep current. The price reflects that — and the depth of what you get back.